We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

110 hedge funds and large institutions have $76.6M invested in Cardiff Oncology in 2025 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 33 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

632% more call options, than puts

Call options by funds: $2.08M | Put options by funds: $284K

47% more capital invested

Capital invested by funds: $52.1M → $76.6M (+$24.4M)

2.56% more ownership

Funds ownership: 37.89% → 40.45% (+2.6%)

6% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 18

2% less funds holding

Funds holding: 112 → 110 (-2)

21% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 33

Holders
110
Holders Change
-2
Holders Change %
-1.79%
% of All Funds
1.34%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
17
Increased
26
Reduced
33
Closed
18
Calls
$2.08M
Puts
$284K
Net Calls
+$1.79M
Net Calls Change
+$61K

Top Buyers

1
Franklin Resources
Franklin Resources
California
+$2.8M
2
Two Sigma Investments
Two Sigma Investments
New York
+$1.21M
3
CS
Candriam SCA
Luxembourg
+$800K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$777K
5
GCP
GSA Capital Partners
United Kingdom
+$490K

Top Sellers

1
William Blair & Company
William Blair & Company
Illinois
-$615K
2
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$430K
3
UBS Group
UBS Group
Switzerland
-$276K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$266K
5
N
Nuveen
North Carolina
-$265K
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
26
Barclays
United Kingdom
$278K +$27K +11,624 +13%
UBS Group
27
UBS Group
Switzerland
$246K -$276K -118,746 -58%
Wells Fargo
28
Wells Fargo
California
$236K +$58.8K +25,311 +43%
N
29
Nuveen
North Carolina
$225K -$265K -114,090 -59%
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$220K -$20.6K -8,867 -10%
HWM
31
HB Wealth Management
Georgia
$201K -$1.04K -448 -0.6%
Assenagon Asset Management
32
Assenagon Asset Management
Luxembourg
$189K – – –
Rockefeller Capital Management
33
Rockefeller Capital Management
New York
$159K -$13.9K -6,000 -10%
Dimensional Fund Advisors
34
Dimensional Fund Advisors
Texas
$157K +$28 +12 +0%
MCM
35
MAI Capital Management
Ohio
$145K -$34.1K -14,701 -22%
Capstone Investment Advisors
36
Capstone Investment Advisors
New York
$144K – – –
AllianceBernstein
37
AllianceBernstein
Tennessee
$137K +$16 +7 +0%
Deutsche Bank
38
Deutsche Bank
Germany
$123K +$100K +43,140 +5,767%
GT
39
Glenview Trust
Kentucky
$121K – – –
Group One Trading
40
Group One Trading
Illinois
$118K +$97.2K +41,874 New
Bank of America
41
Bank of America
North Carolina
$116K -$18.7K -8,057 -16%
VF
42
Virtu Financial
New York
$108K +$89.3K +38,479 New
EP
43
Elkhorn Partners
Nebraska
$107K -$2.09K -900 -2%
Fidelity Investments
44
Fidelity Investments
Massachusetts
$106K +$12.8K +5,502 +17%
Creative Planning
45
Creative Planning
Kansas
$105K -$6.15K -2,648 -7%
I
46
INVST
Indiana
$101K -$10.4K -4,500 -11%
HighTower Advisors
47
HighTower Advisors
Illinois
$96.1K – – –
T. Rowe Price Associates
48
T. Rowe Price Associates
Maryland
$89K – – –
HF
49
HRT Financial
New York
$82K +$35K +15,073 +105%
Mirae Asset Global ETFs Holdings
50
Mirae Asset Global ETFs Holdings
Hong Kong
$80.8K -$88 -38 -0.1%
1
2
3 4 5

CRDF Hedge Fund Activity: Q4 2025 in Review

110 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q4 2025, worth a combined $76.6M — up 47% from $52.1M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of CRDF and 17 opened new positions — a net loss of 1 holder — while 33 trimmed existing stakes and 26 added.

The largest buyer was Franklin Resources, opening a new position worth an estimated $2.8M. The largest seller was William Blair & Company, cutting an estimated $615K.

  • 110 institutional investors held Cardiff Oncology (CRDF) as of Q4 2025, down from 112 in Q3 2025.
  • Funds reported $76.6M of Cardiff Oncology stock for Q4 2025, up 47% quarter-over-quarter.
  • 17 funds opened new Cardiff Oncology positions in Q4 2025 and 18 closed out, a net change of -1 holder.
  • The largest Cardiff Oncology buyer in Q4 2025 was Franklin Resources, an estimated $2.8M added.
  • The largest Cardiff Oncology seller in Q4 2025 was William Blair & Company, an estimated $615K sold.

Based on aggregated 13F filings for Q4 2025.